Actively Recruiting

Phase Not Applicable
Age: 19Years - 80Years
All Genders
NCT04932928

Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients

Led by Seoul National University Hospital · Updated on 2021-06-21

126

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

Sponsors

S

Seoul National University Hospital

Lead Sponsor

I

Inje University

Collaborating Sponsor

AI-Summary

What this Trial Is About

We aim to provide medical nutritional therapy to patients with type 2 diabetes who are on oral hypoglycemic agents or on basal insulin only and monitor the glycemic response with flash glucose monitoring or self-monitoring of blood glucose. Specifically, this is a randomized, open-label, controlled study where half of the study participants will have FreeStyle Libre device on for 12 weeks and compare the change in glycated hemoglobin (HbA1c) value with the patients in the control group.

CONDITIONS

Official Title

Patient-Driven Lifestyle Modification Using FreeStyle Libre in Type 2 Diabetes Patients

Who Can Participate

Age: 19Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 19 to 80 years
  • Diagnosed with type 2 diabetes mellitus
  • Uncontrolled type 2 diabetes with HbA1c between 7.0% and 10.0%
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Diagnosed with other types of diabetes mellitus such as type 1 diabetes
  • Use of prandial insulin
  • Change in diabetes medication in the preceding 3 months
  • Pregnant or lactating women
  • Addiction to drugs or alcohol
  • Use of medications causing drug-induced high blood sugar, such as steroids
  • Severe liver disease
  • End-stage renal disease requiring dialysis
  • Unable to wear continuous glucose monitoring devices due to severe skin reactions or infections
  • Conditions affecting the reliability of HbA1c measurements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Seoul National University Hospital

Seoul, South Korea, 110-744

Actively Recruiting

Loading map...

Research Team

H

Hun Jee Choe, MD

CONTACT

Y

Young Min Cho, MD, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here